Trial
NCT06987968
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Genfit
Collaborators
—
Condition
Hepatic Encephalopathy
Intervention
VS-01 on top of SOC (Active Treatment Group)
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-12